首页 › 基金 › Opti Capital Management, LP › BMRN
Opti Capital Management, LP 对 BMRN 的持仓历史
BIOMARIN PHARMACEUTICAL INC · 医疗保健
Opti Capital Management, LP 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)28,058,000 股,市值约 US$27.5M,约占其申报组合的 1.92%,在其申报持仓中市值排名第 25 位。 Opti Capital Management, LP 最近 11 个申报季度中有 9 个季度披露了 BMRN 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Opti Capital Management, LP 对 BMRN 的持仓演变
Opti Capital Management, LP 于 Q1 2024 首次披露 BMRN 持仓:7,600,000 股(约 US$7.5M)。 该持仓在 Q4 2024 达到峰值 13,733,000 股,市值约 US$12.81B。 在 9 次申报中,Opti Capital Management, LP 0 次增持、1 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 28,058,000 股、市值约 US$27.5M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 7.60M | $7.48M | 新进 |
| Q2 2024 | 7.60M | $7.57M | 持有 |
| Q4 2024 | 13.73M | $12.81B | 新进 |
| Q1 2025 | 13.73M | $13.03M | 持有 |
| Q3 2025 | 32.06M | $30.50M | 新进 |
| Q4 2025 | 32.06M | $30.90M | 持有 |
| Q1 2026 | 28.06M | $27.13M | 减持 |
| Q2 2026 | 28.06M | $27.34M | 持有 |
| Q3 2026 | 28.06M | $27.45M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BMRN 与 13F 数据
BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 27 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$430.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BMRN 的基金
- PRIMECAP MANAGEMENT CO/CA/ 14.99M 股 · $899.34M · Q3 2026
- 维京环球投资 7.62M 股 · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.17M 股 · $430.39M · Q3 2026
- Deep Track Capital, LP 6.37M 股 · $382.46M · Q3 2026
- Vestal Point Capital, LP 5.53M 股 · $331.50M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.03M 股 · $121.51M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M 股 · $109.58M · Q3 2026
更多关于 Opti Capital Management, LP
常见问题
How long has Opti Capital Management, LP held BMRN?
Opti Capital Management, LP has disclosed BMRN holdings in 9 of the last 11 reported quarters, going back to Q1 2024.
What is Opti Capital Management, LP's current position in BMRN?
As of Q3 2026, Opti Capital Management, LP holds 28.06M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $27.45M, representing 1.92% of its reported portfolio and ranking #25.
Has Opti Capital Management, LP been buying or selling BMRN?
In the latest 13F filing (Q3 2026), Opti Capital Management, LP held unchanged its position in BMRN. The position peaked in Q4 2024 at 13.73M shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.